Evidence mapPaperPMID 38726425Full record

ArticleFood science & nutrition2024

Network medicine-based analysis of the hepatoprotective effects of

Jing Wei, Sihua Wang, Junze Huang, Xinhua Zhou, Zhengming Qian, Tingbiao Wu, Qing Fan, Yongyin Liang, Guozhen Cui

Abstract read
In one paragraph

Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. A Triterpenoid-Enriched GLE70 Fraction FromFood science & nutrition · 2026
    Article
  2. Article
  3. Article
  4. GGV formula attenuates CClFrontiers in nutrition · 2025
    Article
  5. Hepatoprotective effects ofFood science & nutrition · 2024
    Article
  6. Network Medicine: A Potential Approach for Virtual Drug Screening.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing WeiSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.
Sihua WangSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.
Junze HuangSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.
Xinhua ZhouGuangzhou Eighth People's Hospital Guangzhou Medical University Guangzhou China.
Zhengming QianDongguan HEC Cordyceps R&D Co., Ltd. Dongguan China.
Tingbiao WuSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.
Qing FanBasic Medical Science Department Zhuhai Campus of Zunyi Medical University Zhuhai China.
Yongyin LiangSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.
Guozhen CuiSchool of Bioengineering Zhuhai Campus of Zunyi Medical University Zhuhai China.ORCID https://orcid.org/0000-0002-7639-2456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcoholic liver disease (ALD) is characterized by high morbidity and mortality, and mainly results from prolonged and excessive alcohol use.

Indexed as

alcoholic liver diseaseAmomum villosum  Lour.hepatoprotective effectsnetwork medicine

Identifiers

PMID38726425
PMCPMC11077240

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.